Foghorn Therapeutics Inc (FHTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -52,619 | -36,770 | -18,834 | -86,620 | -67,117 |
| Depreciation Amortization | 910 | 414 | 9 | -1,493 | -685 |
| Accounts payable and accrued liabilities | -573 | -463 | 284 | -2,475 | -2,809 |
| Other Working Capital | -23,940 | -17,004 | -9,284 | -32,266 | -24,147 |
| Other Operating Activity | 12,394 | 8,855 | 3,857 | 22,448 | 18,871 |
| Operating Cash Flow | $-63,828 | $-44,968 | $-23,968 | $-100,406 | $-75,887 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -97,266 | -93,264 | -51,124 | -261,470 | -221,821 |
| PPE Investments | -50 | -50 | -28 | -906 | -427 |
| Purchase Of Investment | 196,124 | 156,549 | 80,553 | 232,472 | 170,053 |
| Investing Cash Flow | $98,808 | $63,235 | $29,401 | $-29,904 | $-52,195 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 442 | 393 | 139 | 106,013 | 106,009 |
| Other Financing Activity | 0 | 0 | 0 | -585 | -585 |
| Financing Cash Flow | $442 | $393 | $139 | $105,428 | $105,424 |
| Beginning Cash Position | 57,162 | 57,162 | 57,162 | 82,044 | 82,044 |
| End Cash Position | 92,584 | 75,822 | 62,734 | 57,162 | 59,386 |
| Net Cash Flow | $35,422 | $18,660 | $5,572 | $-24,882 | $-22,658 |
| Free Cash Flow | |||||
| Operating Cash Flow | -63,828 | -44,968 | -23,968 | -100,406 | -75,887 |
| Capital Expenditure | -50 | -50 | -28 | -906 | -427 |
| Free Cash Flow | -63,878 | -45,018 | -23,996 | -101,312 | -76,314 |